date:Feb 13, 2019
conditions. In fact, these products could be unsafe and could prevent a patient from seeking proper treatment.
FDA Commissioner Dr. Scott Gottlieb said in a statement, Science and evidence are the cornerstone of the FDAs review process and are imperative to demonstrating medical benefit, especially when a product is marketed to treat serious and complex diseases like Alzheimers. Alzheimers is a challenging disease that, unfortunately, has no cure. Any products making unproven drug claims could